SUGAPOL-M
MRP: 580
Packaging: 10x10
Pack Type: tablet
Composition:
Glimepiride 2mg + Metformin 500mg (In SR)
Indication:
Type 2 diabetes not responding to single agents or dual therapy
Description:
This combination of Glimepiride 2mg and Metformin 500mg (SR) is an oral anti-diabetic medication used for the management of Type 2 Diabetes Mellitus. It helps in controlling blood sugar levels in adults who do not respond adequately to either drug alone.
Glimepiride is a sulfonylurea that increases insulin secretion from the pancreas.
Metformin SR (Sustained Release) is a biguanide that reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.
This dual mechanism offers effective glycemic control, especially in overweight patients.
Tags:
- Combines insulin secretion and insulin sensitivity improvement
- Helps maintain stable blood glucose levels
- Convenient once-daily dose (SR formulation)
- Aids in long-term glycemic control
- Reduces risk of diabetes-related complications
Usage Information
Dosage
Usual dose: One tablet once daily with food Dose may be adjusted based on blood glucose levels Always follow physician’s guidance
Side Effects
Hypoglycemia (low blood sugar) Nausea, diarrhea (due to Metformin) Headache or dizziness Weight gain (possible with Glimepiride) Rare: Lactic acidosis (serious, seek immediate care)
Contraindications
Type 1 Diabetes Diabetic ketoacidosis Severe kidney or liver dysfunction Hypersensitivity to any component Heart failure or recent myocardial infarction (Metformin caution)
Availability
Glimepiride and Metformin tablet Type 2 diabetes control medicine Blood sugar lowering tablets Dual oral anti-diabetic combination Metformin SR with Glimepiride